MedPath

A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates

Not Applicable
Completed
Conditions
Cow Milk Allergy
Interventions
Dietary Supplement: Amino acid based formula
Registration Number
NCT01940068
Lead Sponsor
United Pharmaceuticals
Brief Summary

The purpose of this study is to evaluate the impact of a new Amino-acid based formula on allergic symptoms and growth of infants with cow's milk protein allergy and intolerant to extensively hydrolysed formulas;

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • less than 18 months old
  • with a proven cow's milk protein allergy by a double blind placebo controlled food challenge or a positive Skin prick test (>=6mm) or specific immunoglobulin E >= 5 kilo-unit/L or combination
  • still symptomatic while fed an extensively hydrolysed formula
Exclusion Criteria
  • Exclusively breast fed infants
  • non allergic digestive enteropathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
New Thickened Amino acid based formulaAmino acid based formula-
Amino acid based formulaAmino acid based formula-
Primary Outcome Measures
NameTimeMethod
Number of withdrawal for intolerance1 month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Necker Children's Hospital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath